Population pharmacokinetics of artesunate and its active metabolite dihydroartemisinin
Artemisinin compounds are the most potent anti-malarial drugs available in the market. Today, malaria treatment is largely relies on the artemisinin-based combination therapies. Artesunate (AS) is the most widely used artemisinin derivative. In this thesis, we characterized the population pharmacoki...
Main Author: | Tan, Bee San |
---|---|
Other Authors: | Fleckenstein, Lawrence L. |
Format: | Others |
Language: | English |
Published: |
University of Iowa
2009
|
Subjects: | |
Online Access: | https://ir.uiowa.edu/etd/442 https://ir.uiowa.edu/cgi/viewcontent.cgi?article=1627&context=etd |
Similar Items
-
Population pharmacokinetics of artesunate and dihydroartemisinin in children and pregnant women with malaria
by: Morris, Carrie Ann
Published: (2014) -
Population pharmacokinetics and pharmacodynamics of the artesunate–mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children
by: Monia Guidi, et al.
Published: (2019-04-01) -
Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated <it>Plasmodium falciparum</it> malaria in India
by: Gargano Nicola, et al.
Published: (2012-07-01) -
Population pharmacokinetics of telapristone and its active metabolite CDB-4453
by: Morris, Denise Nichole
Published: (2011) -
Population pharmacokinetics of mefloquine given as a 3-day artesunate–mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug-resistant area along the Thai–Myanmar border
by: Richard M. Hoglund, et al.
Published: (2018-09-01)